Independent pharmacists will be better prepared for their new role to enhance patient care and help health plans improve their ratings under the Centers for Medicare and Medicaid (CMS) Star Rating system after attending this year’s ThoughtSpot 2014 meeting, Good Neighbor Pharmacy and AmerisourceBergen’s annual meeting in Las Vegas.
The California State Board of Pharmacy is considering new regulations that would require pharmacies throughout the state to provide translated labels on prescription drug bottles.
Here's what pharmacists were reading, talking, posting, and tweeting about throughout July 2014.
A patient’s chance of being prescribed highly addictive painkillers such as OxyContin and Vicodin can depend on where they live, according to a report from the Centers for Disease Control and Prevention.
With evidence that more people are using it a recreational drug, the Kansas Board of Pharmacy has recommended adding promethazine with codeine syrup to the list of drugs tracked by the state.
It’s been more than four decades since FDA approved naloxone, which can restore breathing in people overdosing on opiate drugs such oxycodone, hydrocodone, and heroin.
FDA gives the nod to Purdue Pharma's Targiniq ER.
For newly fledged pharmacists, a few solid tips on how to honor your patients, your profession, and yourselves.
McKesson's new Adherence Performance reporting solution will provide actionable data to identify patients more quickly than pharmacies can do using a manual method.
Colchicine therapy, an effective anti-inflammatory agent for gout, is a promising treatment for preventing recurrent pericarditis. However, some patients have discontinued its use because of gastrointestinal intolerance, according to a report published online for the American Journal of Health-System Pharmacy, which will appear in the August 1 edition.
Patients who received the combo along with statin therapy did not experience higher rates of prevention of major vascular events compared with those taking placebo and statins.
That’s the objective of many healthcare providers. Brian Isetts, a pharmacy professor at the University of Minnesota and a former policy fellow at CMS, addressed the topic at the PPSI Annual Breakfast Meeting in Orlando.
The Centers for Disease Control and Prevention recently launched a new webpage urging pharmacists to take a lead role in the government’s smoking cessation efforts.
Members of the Joint Commission of Pharmacy Practitioners (JCPP) recently released a new resource document that details the patient care process. The document was developed over a two-year period and aims to “promote consistency in patient care service delivery across the profession.”
The Drug Enforcement Administration (DEA) ruled this week that the pain reliever tramadol is now classified as a Schedule IV controlled substance (CS).
Written by a pharmacist who has endured through thick and through thin, these 10 tips remind pharmacy professionals that they have plenty to take pride in.
As specialty pharmaceuticals consume more of the healthcare dollar, the role of managed care pharmacy will be critical.
Go ahead. Blame Obamacare. It won't make any difference.
Industry and academe collaborate on opportunities for young people to explore the range of careers in pharmacy.
Electronic prescribing of controlled substances isn't much of an improvement over previous practice.
Letters, e-mails, posts, and comments from Drug Topics readers.
New Rx, generics, OTC, and devices for pharmacists.
Two trials involving 100 totally blind individuals with circadian rhythm sleep disorders established the efficacy of the new product.
Specialty pharmacy is big and getting bigger. Some even call it a gold rush. Here are tips for those who'd like a piece of the action.
Available data indicated "serious risks associated with the use of aspirin, including increased risk of bleeding in the stomach and brain."
